Astellas Pharma Competitors and Similar CompaniesClear all

Pfizer's competitors and similar companies include Immunomedics, Urovant Sciences and Hetero.

	Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.	Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.	Urovant Sciences Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions.	Hetero Hetero is a generic pharmaceutical company engaged in the development, manufacturing, and marketing of chemical and biologic drugs.
Founding Date	Founding Date 1849	Founding Date 1982	Founding Date 2016	Founding Date 1993
Type	Type Public	Type Subsidiary	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech pharma therapy	Tags Manufacturing & Industrial biotech drug development pharma
Locations	Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more	Locations Morris Plains, US HQ	Locations Irvine, US HQ Basel, CH	Locations Hyderabad, IN HQ Norwest, AU Sao Paulo, BR Beijing, CN Nanjing Shi, CN Nanjing Shi, CN Bogotá, CO see more
Employees	Employees 88,0006% increase	Employees 1041% decrease	Employees 3950% increase	Employees 6,7343% increase
Financial
Revenue (est.)	Revenue (est.) $63.6b (FY, 2024)	Revenue (est.) $295k (FY, 2019)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $17.9b (FY, 2024)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $45.8b (FY, 2024)	Gross profit $295k (FY, 2019)	Gross profit N/A	Gross profit N/A
Net income	Net income $8.1b (FY, 2024)	Net income ($357.3m) (FY, 2019)	Net income ($146.7m) (FY, 2020)	Net income N/A
Operating ⚠
Countries	Countries 125 (FY, 2021)	Countries N/A	Countries N/A	Countries 126 (Jan, 2021)
Patent Applications (US)	Patent Applications (US) N/A	Patent Applications (US) 230 (Sep, 2022)	Patent Applications (US) N/A	Patent Applications (US) 23 (Jan, 2021)
Patents (US)	Patents (US) N/A	Patents (US) 405 (Sep, 2022)	Patents (US) N/A	Patents (US) 38 (Jan, 2021)